指南与共识重症综合管理与镇静镇痛

重症监护药学服务立场文件:2020更新

Position Paper on Critical Care Pharmacy Services: 2020 Update.
指南 / 共识 · Crit Care Med · 2020-01-01
一句话结论重症监护药师是多专业重症团队的必要成员,本立场文件更新了其活动范围与ICU药学服务推荐。

美国重症医学会、美国临床药学学院重症实践与研究网络、美国卫生系统药师协会联合召集15名药师组成工作组,采用改良德尔菲法(共识阈值>66%)制定共识。共产生82条推荐声明,其中44条为原始推荐、38条为新推荐;按ICU服务级别分类,涵盖患者照护(34条)、质量改进(21条)、研究与学术(9条)、培训与教育(10条)及职业发展(8条)五个领域。文件明确了重症监护药师的职责与ICU药学服务范围,并建议各利益相关方实施这些推荐。

要点

  • 共识由15名药师组成的联合工作组采用改良德尔菲法制定,共识阈值>66%。
  • 共82条推荐:44条原始推荐、38条新推荐,按ICU服务级别分类。
  • 患者照护领域34条,主要涉及重症监护药师职责与药学服务。
  • 质量改进领域21条,涉及患者与用药安全、临床质量项目及分析。
  • 研究与学术9条、培训与教育10条、职业发展8条。

适用人群与场景

  • 重症监护药师及ICU多专业团队,适用于不同ICU服务级别与设置。

处置流程与药物剂量

  • 患者照护领域34条推荐,主要涉及重症监护药师职责与药学服务。
  • 质量改进领域21条推荐,涉及重症监护药师在患者与用药安全、临床质量项目及分析中的作用。
  • 研究与学术领域9条推荐。
  • 培训与教育领域10条推荐。
  • 职业发展领域8条推荐。

研究设计与关键结果

  • 制定机构:美国重症医学会、美国临床药学学院重症实践与研究网络、美国卫生系统药师协会联合工作组,15名药师。
  • 方法:改良德尔菲法,共识阈值>66%;既往推荐经投票保留、修订或废止。
  • 推荐按ICU服务级别分类,分为患者照护、质量改进、研究与学术、培训与教育、职业发展五个领域。
  • 共82条推荐声明:44条原始推荐、38条新推荐;患者照护34条、质量改进21条、研究与学术9条、培训与教育10条、职业发展8条。

证据类型、等级与局限

  • 证据类型:多组织立场文件(指南/共识),采用改良德尔菲法达成共识(>66%同意)。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为重症监护药师是多专业重症团队的必要成员,本文件划定其活动与ICU药学服务范围。
  • 作者建议所有利益相关方努力实施所提供推荐,并持续改进重症患者照护。

指南或共识出处

  • Position Paper on Critical Care Pharmacy Services: 2020 Update(重症监护药学服务立场文件:2020更新),发表于Critical Care Medicine。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To provide a multiorganizational statement to update recommendations for critical care pharmacy practice and make recommendations for future practice. A position paper outlining critical care pharmacist activities was last published in 2000. Since that time, significant changes in healthcare and critical care have occurred.

DESIGN: The Society of Critical Care Medicine, American College of Clinical Pharmacy Critical Care Practice and Research Network, and the American Society of Health-Systems Pharmacists convened a joint task force of 15 pharmacists representing a broad cross-section of critical care pharmacy practice and pharmacy administration, inclusive of geography, critical care practice setting, and roles. The Task Force chairs reviewed and organized primary literature, outlined topic domains, and prepared the methodology for group review and consensus. A modified Delphi method was used until consensus (> 66% agreement) was reached for each practice recommendation. Previous position statement recommendations were reviewed and voted to either retain, revise, or retire. Recommendations were categorized by level of ICU service to be applicable by setting and grouped into five domains: patient care, quality improvement, research and scholarship, training and education, and professional development.

MAIN RESULTS: There are 82 recommendation statements: 44 original recommendations and 38 new recommendation statements. Thirty-four recommendations represent the domain of patient care, primarily relating to critical care pharmacist duties and pharmacy services. In the quality improvement domain, 21 recommendations address the role of the critical care pharmacist in patient and medication safety, clinical quality programs, and analytics. Nine recommendations were made in the domain of research and scholarship. Ten recommendations were made in the domain of training and education and eight recommendations regarding professional development.

CONCLUSIONS: Critical care pharmacists are essential members of the multiprofessional critical care team. The statements recommended by this taskforce delineate the activities of a critical care pharmacist and the scope of pharmacy services within the ICU. Effort should be made from all stakeholders to implement the recommendations provided, with continuous effort toward improving the delivery of care for critically ill patients.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Lat I, Paciullo C, Daley MJ, et al. Position Paper on Critical Care Pharmacy Services: 2020 Update. Crit Care Med. 2020. PMID: 32826496. doi:10.1097/CCM.0000000000004437

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。